Table 3

Contents and results of radiotherapy (with or without chemotherapy) for postoperative recurrent esophageal cancer in past studies
author year No. regimen median observation period 2-year survival rate 5-year survival rate
JL Raoul12) 1995 24 RT† + CDDP*+5-FU 14 months 17.1% n.a. ‡
K Nemoto13) 2001 33 RT alone (21) or RT + CDDP+ 5-FU (12) n.a. 15% n.a.
Y Nishimura11) 2003 13 RT + CDDP+5-FU 9.5 months 19% n.a.
Y Shioyama14) 2007 82 RT ± chemotherapy n.a. 22% 11%
K Maruyama15) 2011 23 RT ± chemotherapy n.a. 31% 24%
Current study 2012 30 RT + CDGP§+ 5-FU 72 months 46.0% 27.0%

†RT: radiotherapy, * CDDP: cisplatin, § CDGP: nedaplatin, # 5-FU: 5-fluorouracil, ‡n.a.: not available.

Jingu et al.

Jingu et al. BMC Cancer 2012 12:542   doi:10.1186/1471-2407-12-542

Open Data